M.D. Anderson Cancer Center
This study aims to evaluate the impact of a Transitional Pain Service (TPS) on hospital readmission rates, opioid consumption, and chronic post-surgical pain(CPSP), Despite increasing recognition of the benefits of integrated transitional pain care, there are limited prospective data evaluating its impact on 30-day readmissions, longitudinal opioid use, and CPSP. This protocol will systematically collect prospective patient data to assess these outcomes.
Primary Objective: To compare the 30-day hospital readmission rate in patients seen by to the Transitional Pain Service. Secondary Objectives: 1. To evaluate reduction in opioid use (MME) at 30, 60, 90, 180, and 365 days. 2. To evaluate patient reported outcomes using BPI, CAGE-AID, SOAPP-14, ESAS, PROMIS-29 at 30, 60, 90, 180, and 365 days to assess patient-reported quality of life and pain outcomes longitudinally. 3. To evaluate the incidence of CPSP 4. To assess demographic and clinical predictors of readmission and opioid reduction. 5. Compare outcomes between TPS patients who receive a…
Inclusion Criteria: Chronic pain syndrome Patients with a h/o or current substance use Patients on a daily opioid dose (morphine equivalency) of ≥90 Consulted for transitional pain service Exclusion Criteria: Not seen by transitional pain service
Participants will receive a brief, skills-based mini-CBT group intervention
Arctuva estimate
Verify or correct the compensation shown for this listing.